Portfolio – KdT Ventures

Our Companies

Changing the World at the Molecular Level

Abridge

A patient's healthcare story is siloed, disjointed and inaccessible. Abridge started as a collaboration between the University of Pittsburgh Medical Center (UPMC) and Carnegie Mellon University (CMU) to build speech, voice, and language technologies to better capture our healthcare stories and empower the patient and unburden practitioners.

Azitra

Azitra has developed a platform to deliver therapeutic proteins, including a live biotherapeutic skin bacteria to correct the microbial balance and deliver therapeutic proteins directly to the skin.

Checkerspot

Checkerspot is a designed materials company built on the shoulders of genetic engineering of heterotrophic algae. Checkerspot is redefining and expanding the “palette” for material science.

Elemental Machines

Elemental Machines is revolutionizing science-based industries with a smart lab platform that offers powerful, data-driven insights to improve laboratory operations, research, development, and manufacturing outcomes.

Hi Fidelity Genetics

Hi Fidelity Genetics aspires to be a world-class non-GMO seed company providing a robust end-to-end predictive breeding platform generating the best crop genomes in the world.

Patch'd

Patch’d is on a mission to prevent sepsis. Unlike other sepsis companies which focus on the inpatient setting (where only 20% of sepsis cases start/occur), Patch’d powers a simple wearable device with advanced computation to predict sepsis in the outpatient setting.

Path AI

PathAI’s platform provides end-to-end data-driven pathology analysis, resulting in fast, accurate and standardized pathologic diagnoses while simultaneously elucidating novel biology previously unexplored on the slide.

Rejuvenate Bio

Rejuvenate targets gene therapies directed at curing specific disease states associated with old age in companion animals. These treatements have the potential to apply to humans, improving overall health and extending lifespans.

Solugen

Solugen is creating cutting-edge chemistries that are safer to use, more cost-effective and environmentally-friendly than traditional petrochemicals through an extremely efficient enzymatic reaction.

Terray Therapeutics

Terray Therapeutics created and powers a novel spatially encoded screening and optimization platform (tArray) to develop novel treatments for historically intractable causes of human disease.

Theator

Theator is providing real-time guidance in surgery, converting the operating room to a cockpit. Theator’s computer vision and machine-learning platform analyzes visual surgical content to present surgeons with aggregated rich insights derived from clinical data.

Tierra Biosciences

Tierra Biosciences accelerates bio-discovery through cell-free systems. Tierra Biosciences Next Generation Expression platform allows for high-throughput data collection that is real and experimentally validated at speeds of simulation-based approaches.

Braid Health

Braid powers the premier AI-platform for radiology and the healthcare industry. With self-improving AI at its core, Braid enhances diagnosis accuracy and unlocks the next generation of augmented radiology.

Debut Biotechnology

Debut manufactures high value molecules by combining custom designed immobilized enzymes with continuous biomanufacturing processes.

Andes

Andes designs and manufactures a bio-based agricultural solution that leverages the expression of beneficial genes from the soil microbiome to boost crop production. Their bacteria interact symbiotically with plants at a molecular level and fix atmospheric nitrogen.

Circularis

Circularis discovers and enhances promoters across any cell type to drive specificity and increase production of protein. Acquired by Ginko in 2022.

Dyno Therapeutics

Dyno Therapeutics creates novel adeno-associated virus (AAV) vectors that enable safe, efficient and targeted in vivo delivery for revolutionary new gene therapies. Dyno is systematically mapping the relationship between capsid sequence and function and optimizing AAV for improved therapeutic efficacy.

Xilis

Xilis is developing next generation organoid technologies to guide precision therapy for cancer patients and accelerate drug discovery.

Revel

Using synthetic biology to design and manufacture superior ingredients, starting with coffee.

Elegen

Elegen powers the engineering of biology through its novel gene synthesis technology, enabling biology at the speed of DNA.

STRM.BIO

STRM.BIO is leveraging extracellular vesicles to usher in a new age of Gene Therapies.

Dimension Inx

Dimension Inx is the materials specialist of 3D bioprinting.

Onc.AI

Transforming oncology decision support with deep-learning and novel imaging biomarkers.

Faeth

Faeth makes personalized, precision, effective diets for cancer patients.

Remedy Robotics

Remedy Robotics is developing autonomous navigation software for vascular surgical robotic systems, significantly expanding access to life-saving surgical interventions such as mechanical thrombectomy for stroke.

SeQure

SeQure Dx empowers assessment of on and off-target editing for gene editing therapeutics.

Marigold Health

Marigold is an Anonymous Social Network where people with mental health & substance use conditions support each other.

Parthenon

Parthenon Therapeutics is reprogramming the tumor microenvironment to beat cancers.

Modulus

Modulus is engineering next-generation immune cell therapies, starting with Natural Killer cells rationally designed for the treatment of solid tumors.

Zymochem

Zymochem is developing microbes and bioprocesses for the eco-friendly and profitable production of chemicals from renewable resources.

Molecule

Molecule is decentralizing drug development by allowing investors to fund drug R&D at the earliest stages

Cypris Materials

Delivering the next generation of sustainable color coatings through the use of scalable structural polymers.

Tavros Therapeutics

Tavros is an Integrated high-throughput genomics platform to discover next generation cancer therapies .

Canaery

Canaery is unlocking a new molecular layer by digitizing scent to better understand any given environment.

Tacit Therapeutics

Tacit is a non-immunogenic gene editing platform to treat genetic diseases.

Equii

EQUII is redefining the protein source on our plate from meat to staples, by using bioinformatics, fermentation and culinary sciences.

Character

Harnessing patient data to develop new precision medicines

Elo Life Systems

Appling precision gene editing to the agricultural and food and beverage industries

Nosis Bio

Optimizing peptides to realize the cell-specific delivery of peptide-drug conjugates

Aperiam Bio

Designing proteins for human and planetary health

Perceptive

Autonomous surgery machinery for the dental industry powered by novel precision imaging

Syenex

Extracellular vesicle platform for the delivery of therapeutic payloads to undruggable tissue and cells

March Biosciences is pioneering next-generation CAR-T cell therapies for T-cell cancers, solving a key technical challenge that has historically prevented effective treatment of these aggressive blood cancers while demonstrating promising early clinical results in patients with limited therapeutic options.